Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMGN |
---|---|---|
09:32 ET | 52302 | 269.99 |
09:33 ET | 2146 | 270.5411 |
09:35 ET | 8992 | 270.11 |
09:37 ET | 13034 | 269.705 |
09:39 ET | 7873 | 269.44 |
09:42 ET | 5830 | 269.96 |
09:44 ET | 1188 | 269.76 |
09:46 ET | 3181 | 269.76 |
09:48 ET | 2428 | 270.15 |
09:50 ET | 2991 | 270.11 |
09:51 ET | 2526 | 270.34 |
09:53 ET | 3113 | 270.39 |
09:55 ET | 2641 | 270.38 |
09:57 ET | 6631 | 270.07 |
10:00 ET | 901 | 270.02 |
10:02 ET | 4122 | 270.7 |
10:04 ET | 3200 | 270.28 |
10:06 ET | 5200 | 270.31 |
10:08 ET | 5522 | 270.84 |
10:09 ET | 4159 | 270.79 |
10:11 ET | 1971 | 271.26 |
10:13 ET | 2300 | 271.3 |
10:15 ET | 3362 | 271.805 |
10:18 ET | 5673 | 271.78 |
10:20 ET | 2275 | 271.29 |
10:22 ET | 100 | 271.105 |
10:24 ET | 837 | 271.06 |
10:26 ET | 569 | 270.64 |
10:27 ET | 1743 | 270.95 |
10:29 ET | 3820 | 270.84 |
10:31 ET | 4445 | 270.61 |
10:33 ET | 313 | 270.68 |
10:36 ET | 2632 | 270.69 |
10:38 ET | 12140 | 270.59 |
10:40 ET | 22931 | 270.16 |
10:42 ET | 725 | 270.0345 |
10:44 ET | 6307 | 270.05 |
10:45 ET | 4064 | 270.085 |
10:47 ET | 1393 | 269.9237 |
10:49 ET | 2590 | 269.97 |
10:51 ET | 1800 | 270.18 |
10:54 ET | 1507 | 270.5962 |
10:56 ET | 800 | 270.8 |
10:58 ET | 805 | 271.02 |
11:00 ET | 1955 | 271.015 |
11:02 ET | 3153 | 271.01 |
11:03 ET | 3525 | 270.75 |
11:05 ET | 280 | 270.57 |
11:07 ET | 600 | 270.545 |
11:09 ET | 1767 | 270.5579 |
11:12 ET | 4685 | 270.62 |
11:14 ET | 536 | 270.131 |
11:16 ET | 1434 | 269.94 |
11:18 ET | 3163 | 269.65 |
11:20 ET | 2206 | 269.55 |
11:21 ET | 2120 | 269.515 |
11:23 ET | 1950 | 269.735 |
11:25 ET | 1340 | 269.62 |
11:27 ET | 1145 | 269.79 |
11:30 ET | 4859 | 269.78 |
11:32 ET | 2651 | 269.875 |
11:34 ET | 1324 | 269.69 |
11:36 ET | 3180 | 269.69 |
11:38 ET | 1395 | 269.605 |
11:39 ET | 2240 | 269.46 |
11:41 ET | 3491 | 269.64 |
11:43 ET | 1434 | 269.65 |
11:45 ET | 1053 | 269.57 |
11:48 ET | 1037 | 269.35 |
11:50 ET | 1800 | 269.68 |
11:52 ET | 1223 | 269.5 |
11:54 ET | 700 | 269.38 |
11:56 ET | 900 | 269.58 |
11:57 ET | 2159 | 269.75 |
11:59 ET | 801 | 269.6764 |
12:01 ET | 1000 | 269.58 |
12:03 ET | 3026 | 269.575 |
12:06 ET | 1475 | 269.4266 |
12:08 ET | 900 | 269.54 |
12:10 ET | 1391 | 269.53 |
12:12 ET | 903 | 269.46 |
12:14 ET | 540 | 269.48 |
12:15 ET | 2366 | 269.42 |
12:17 ET | 3500 | 269.6 |
12:19 ET | 1578 | 269.4 |
12:21 ET | 1800 | 269.43 |
12:24 ET | 805 | 269.56 |
12:26 ET | 1286 | 269.78 |
12:28 ET | 1126 | 269.8275 |
12:30 ET | 1775 | 269.805 |
12:32 ET | 1500 | 269.7 |
12:33 ET | 450 | 269.775 |
12:35 ET | 2966 | 269.71 |
12:37 ET | 600 | 269.61 |
12:39 ET | 200 | 269.67 |
12:42 ET | 455 | 269.72 |
12:44 ET | 2300 | 269.75 |
12:46 ET | 1412 | 269.665 |
12:48 ET | 962 | 269.69 |
12:50 ET | 800 | 269.85 |
12:51 ET | 870 | 269.79 |
12:53 ET | 915 | 269.72 |
12:55 ET | 1631 | 269.555 |
12:57 ET | 300 | 269.64 |
01:00 ET | 3637 | 269.83 |
01:02 ET | 1741 | 269.83 |
01:04 ET | 1309 | 269.88 |
01:06 ET | 2689 | 269.93 |
01:08 ET | 3632 | 269.82 |
01:09 ET | 2092 | 269.95 |
01:11 ET | 2160 | 270.15 |
01:13 ET | 1327 | 270.12 |
01:15 ET | 1020 | 270.18 |
01:18 ET | 600 | 270 |
01:20 ET | 2111 | 270.265 |
01:22 ET | 2967 | 270.03 |
01:24 ET | 1300 | 270.02 |
01:26 ET | 900 | 270.07 |
01:27 ET | 2987 | 270.21 |
01:29 ET | 2973 | 270.21 |
01:31 ET | 1316 | 270 |
01:33 ET | 330 | 269.95 |
01:36 ET | 4210 | 269.9 |
01:38 ET | 1739 | 269.79 |
01:40 ET | 3771 | 269.92 |
01:42 ET | 1394 | 269.75 |
01:44 ET | 833 | 269.63 |
01:45 ET | 800 | 269.56 |
01:47 ET | 3123 | 269.68 |
01:49 ET | 3383 | 269.5 |
01:51 ET | 3458 | 269.44 |
01:54 ET | 2074 | 269.39 |
01:56 ET | 2627 | 269.4675 |
01:58 ET | 711 | 269.45 |
02:00 ET | 3030 | 269.42 |
02:02 ET | 2007 | 269.58 |
02:03 ET | 3713 | 269.5975 |
02:05 ET | 4088 | 269.9 |
02:07 ET | 600 | 269.85 |
02:09 ET | 2516 | 269.825 |
02:12 ET | 1386 | 270.09 |
02:14 ET | 2484 | 270.11 |
02:16 ET | 1514 | 269.8645 |
02:18 ET | 1999 | 269.9699 |
02:20 ET | 1232 | 269.89 |
02:21 ET | 705 | 269.9 |
02:23 ET | 2699 | 269.99 |
02:25 ET | 3377 | 269.721 |
02:27 ET | 3377 | 269.79 |
02:30 ET | 1830 | 269.765 |
02:32 ET | 2153 | 269.865 |
02:34 ET | 2359 | 270.145 |
02:36 ET | 5320 | 269.92 |
02:38 ET | 1653 | 270.07 |
02:39 ET | 854 | 270.0967 |
02:41 ET | 1500 | 270.18 |
02:43 ET | 1500 | 270.04 |
02:45 ET | 4069 | 270.08 |
02:48 ET | 1105 | 270.125 |
02:50 ET | 1877 | 270.17 |
02:52 ET | 2260 | 270.12 |
02:54 ET | 1275 | 270.1157 |
02:56 ET | 1297 | 270.0169 |
02:57 ET | 1100 | 270.01 |
02:59 ET | 1608 | 270.03 |
03:01 ET | 2482 | 270.12 |
03:03 ET | 3821 | 270.2 |
03:06 ET | 3143 | 270.1 |
03:08 ET | 3115 | 269.82 |
03:10 ET | 2850 | 270.16 |
03:12 ET | 2539 | 270.03 |
03:14 ET | 1400 | 270.19 |
03:15 ET | 4181 | 270.175 |
03:17 ET | 2400 | 270.03 |
03:19 ET | 1900 | 269.99 |
03:21 ET | 1310 | 269.7825 |
03:24 ET | 3914 | 269.76 |
03:26 ET | 2489 | 269.85 |
03:28 ET | 4150 | 269.88 |
03:30 ET | 1774 | 269.835 |
03:32 ET | 4656 | 269.71 |
03:33 ET | 5107 | 269.66 |
03:35 ET | 1777 | 269.69 |
03:37 ET | 3346 | 269.62 |
03:39 ET | 3614 | 269.81 |
03:42 ET | 4461 | 269.7 |
03:44 ET | 4208 | 269.74 |
03:46 ET | 3548 | 269.845 |
03:48 ET | 7623 | 269.84 |
03:50 ET | 5990 | 269.57 |
03:51 ET | 8401 | 269.3687 |
03:53 ET | 12503 | 269.21 |
03:55 ET | 18208 | 269.13 |
03:57 ET | 17404 | 269.17 |
04:00 ET | 71579 | 269.12 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amgen Inc | 144.0B | 19.1x | +1.96% |
Gilead Sciences Inc | 98.5B | 16.9x | -13.86% |
Bristol-Myers Squibb Co | 102.4B | 12.8x | +4.53% |
Sanofi SA | 117.6B | 11.9x | +17.46% |
AstraZeneca PLC | 196.8B | 33.5x | +2.29% |
HALEON PLC | 37.8B | 24.3x | --- |
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The Company focuses on human therapeutics for the treatment of serious illness. It also offers TEPEZZA (teprotumumab-trbw), KRYSTEXXA (pegloticase) and UPLIZNA (inebilizumab-cdon).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $144.0B |
---|---|
Revenue (TTM) | $26.8B |
Shares Outstanding | 535.2M |
Dividend Yield | 3.17% |
Annual Dividend Rate | 8.5200 USD |
Ex-Dividend Date | 11-16-23 |
Pay Date | 12-08-23 |
Beta | 0.57 |
EPS | $14.07 |
Book Value | $6.86 |
P/E Ratio | 19.1x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | 12.9x |
Operating Margin | 33.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.